PSA and clinical responses to celecoxib in a patient with prostate cancer and bone metastases.
Sonpavde
Guru
G
Hayes
Teresa G
TG
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000473:pathology; D001859:Bone Neoplasms / Q000556:secondary*; D000068579:Celecoxib; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D017430:Prostate-Specific Antigen / Q000187:drug effects*; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology; D011720:Pyrazoles / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*
D016861:Cyclooxygenase Inhibitors; D011720:Pyrazoles; D013449:Sulfonamides; D017430:Prostate-Specific Antigen; D000068579:Celecoxib